The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Alzamend Neuro Inc(NASDAQ:ALZN) 
Alzamend Neuro is preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. With our two current and future product candidates, we aim to bring treatments or cures to market at a reasonable cost as quic...
Alzamend Neuro Number of Twitter Followers
Alzamend Neuro Days Payable Outstanding ttm (DPO)
Alzamend Neuro Op Cashflow Per Share ttm
Alzamend Neuro Free Cashflow Per Share ttm
Alzamend Neuro Cash Per Share ttm
Alzamend Neuro (GAAP) P/E ratio ttm
Alzamend Neuro P/B ratio ttm
No extra charts and metrics for this ticker.